RESTORE: Clinical Trials

4 trials of RESTORE, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 enrolling by invitation, 1 recruiting. 4 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 2, Enrolling by invitation 1, Recruiting 1

Follow RESTORE: new trials by email Literature Review of RESTORE trials Research Report on RESTORE

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer
RESTORE, Enhanced Usual Care - Triple Negative Breast Cancer (TNBC)
Not applicableRecruitingMassachusetts General Hospital752026-07-072026-09-15
Adaptation and Evaluation of RESTORE
RESTORE - Nurse, Burnout, Healthcare Workers
Not applicableEnrolling by invitationUniversity of Wisconsin, Madison4702025-12-022026-11-02
Restoring Energy With Sub-symptom Threshold Optimized Rehabilitation Exercise for Long COVID
Restoring Energy with Sub-symptom Threshold Aerobic Rehabilitation Exercise, Light Stretching/Breathing Exercises - Long Covid19, Exercise Intolerance
Not applicableCompletedColumbia University42023-10-012024-06-06
Remote Education Strategies Training Oncology Residents for End-of-Life Discussions
RESTORE, Medical Interaction and Coaching - Oncology
Not applicableCompletedMcMaster University232023-03-012025-01-15

Conditions studied

Burnout, Psychological (1)  ·  Communication (1)  ·  Neoplasms (1)  ·  Occupational Stress (1)  ·  Post-Acute COVID-19 Syndrome (1)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

Columbia University (1)  ·  Massachusetts General Hospital (1)  ·  McMaster University (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

Anna Norweg, PhD (1)  ·  Kathryn E Post, PhD, RN, ANP-BC (1)  ·  Linsey Steege, PhD (1)  ·  Oren Levine, MD (1)

NIH funding

K08CA286755 (1), R01NR021386 (1)